259 related articles for article (PubMed ID: 19177784)
1. [Antibiotic pharmacoeconomics].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2008 Nov; 25(149):437-8. PubMed ID: 19177784
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effectiveness and costs of antibiotics in respiratory infections].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2011 May; 30(179):327-9. PubMed ID: 21675134
[TBL] [Abstract][Full Text] [Related]
3. Economics of antibiotic use policies.
Paladino JA
Pharmacotherapy; 2004 Dec; 24(12 Pt 2):232S-8S. PubMed ID: 15585453
[TBL] [Abstract][Full Text] [Related]
4. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
Kusowska J
Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
Kusowska J
Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacoeconomics of infection in the intensive care unit].
Grau S; Alvarez-Lerma F
Rev Esp Quimioter; 2008; 21 Spec No 1():26-34. PubMed ID: 18752077
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure.
Spiritus E
Am J Manag Care; 2000 Dec; 6(23 Suppl):S1216-21. PubMed ID: 11187446
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomics of appropriate antimicrobial use.
Davey P
Diagn Microbiol Infect Dis; 1995; 22(1-2):225-9. PubMed ID: 7587044
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
Brixner DI
Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
[No Abstract] [Full Text] [Related]
10. [The pharmacoeconomics of treatment of severe infections in intensive care].
Zambrowski JJ
Ann Fr Anesth Reanim; 2000 May; 19(5):430-5. PubMed ID: 10874445
[TBL] [Abstract][Full Text] [Related]
11. Economics of antibiotic resistance.
Sipahi OR
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact and relevance of antibiotic resistance.
French GL
Adv Drug Deliv Rev; 2005 Jul; 57(10):1514-27. PubMed ID: 15978698
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacoeconomical analysis of antibiotic use at the Clinic For Infectious Diseases of the Clinical Center of Vojvodina].
Stefan-Mikić S; Jovanović J; Jovanović N; Sević S; Vukadinov J; Miucin-Vukadinović I
Med Pregl; 2008; 61 Suppl 1():40-9. PubMed ID: 19248639
[TBL] [Abstract][Full Text] [Related]
14. [Phamacoeconomic analysis of antibiotics use in the Clinical Center of Vojvodina].
Stefan-Mikić S; Jovanović J; Jovanović N; Aleksić-Dordević M; Cvjetković D; Krajcir I
Med Pregl; 2008; 61 Suppl 1():50-8. PubMed ID: 19248640
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomics: disease-based management applications.
Garrelts JC
Pharm Pract Manag Q; 1996 Jul; 16(2):36-40. PubMed ID: 10161609
[TBL] [Abstract][Full Text] [Related]
16. The challenge of prescribing treatment for respiratory tract infections.
Nicolau DP
Am J Manag Care; 2000 May; 6(8 Suppl):S419-26. PubMed ID: 10977481
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic cost control measures in a hospital pharmacy.
Manzo J; Amodio-Groton MA; Kleinmann K
Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
[TBL] [Abstract][Full Text] [Related]
18. [The choice of antimicrobial therapy by application of pharmacoeconomic principles in view of the most frequently isolated pathogens at the Clinic for Infectious Diseases of the Clinical Center of Vojvodina].
Stefan-Mikić S; Sević S; Jovanović N; Cvjetković D; Aleksić-Dordević M
Med Pregl; 2010; 63 Suppl 1():52-9. PubMed ID: 21438205
[TBL] [Abstract][Full Text] [Related]
19. Blood test may lower antibiotic usage in lower respiratory tract infections.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Mar; 15(6):1, 8-9. PubMed ID: 15040383
[No Abstract] [Full Text] [Related]
20. The pharmacoeconomics of acne treatment: where are we heading?
Inglese MJ; Fleischer AB; Feldman SR; Balkrishnan R
J Dermatolog Treat; 2008; 19(1):27-37. PubMed ID: 18273722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
